Copegus®

DRUG2 trials

Sponsors

Gilead Sciences

Conditions

Chronic Hepatitis C InfectionHepatitis C, Chronic

Phase 2

A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

CompletedNCT01225380

Gilead SciencesChronic Hepatitis C Infection

Start: 2010-10-31End: 2013-09-30Updated: 2014-01-28

A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

CompletedNCT01271790

Gilead SciencesHepatitis C, Chronic

Start: 2010-10-31End: 2013-09-30Updated: 2014-02-06